Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women. (Q43181241)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20111659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20111659%20AND%20SRC:MED&resulttype=core&format=json

polycystic ovary syndrome

17 January 2020

main subject

risk factor

0 references

1 reference

1 reference

Carolyn J Alexander

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20111659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Edward P Tangchitnob

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20111659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Norman E Lepor

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20111659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20111659%20AND%20SRC:MED&resulttype=core&format=json

Reviews in Obstetrics & Gynecology

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20111659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20111659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20111659%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

232-239

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20111659%20AND%20SRC:MED&resulttype=core&format=json

Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women

17 January 2020

cites work

1 reference

12 December 2020

Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome

1 reference

12 December 2020

Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance

1 reference

12 December 2020

Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease

1 reference

12 December 2020

Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone

1 reference

12 December 2020

Health implications of overweight and obesity in the United States

1 reference

12 December 2020

Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

1 reference

12 December 2020

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome

1 reference

12 December 2020

Matrix metalloproteinases as mediators of reproductive function

1 reference

12 December 2020

Central role of the adipocyte in the metabolic syndrome

1 reference

12 December 2020

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

12 December 2020

The Relationship between C-Reactive Protein and Carotid Intima-Media Wall Thickness in Middle-Aged Women with Polycystic Ovary Syndrome

1 reference

12 December 2020

Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome

1 reference

12 December 2020

Ultrasound assessment of the polycystic ovary: international consensus definitions.

1 reference

12 December 2020

Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome

1 reference

12 December 2020

Combined oral contraceptives in the treatment of polycystic ovary syndrome

1 reference

12 December 2020

Use of metformin in polycystic ovary syndrome

1 reference

12 December 2020

Pathophysiology and types of dyslipidemia in PCOS.

1 reference

12 December 2020

Obesity and weight loss in polycystic ovary syndrome

1 reference

12 December 2020

Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women

1 reference

12 December 2020

Clomiphene versus metformin for ovulation induction in polycystic ovary syndrome: the winner is ....

1 reference

12 December 2020

The prevalence and features of the polycystic ovary syndrome in an unselected population

1 reference

12 December 2020

Polycystic ovary syndrome

1 reference

12 December 2020

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

1 reference

12 December 2020

Matrix metalloproteinases in cerebrovascular disease

1 reference

12 December 2020

Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state

1 reference

12 December 2020

The role of oral contraceptives in the treatment of hyperandrogenic disorders

1 reference

12 December 2020

Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome

1 reference

12 December 2020

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

1 reference

12 December 2020

Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss

1 reference

12 December 2020

Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients

1 reference

12 December 2020

Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome

1 reference

12 December 2020

Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease

1 reference

12 December 2020

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

12 December 2020

Cardiovascular risk in women with polycystic ovarian syndrome

1 reference

12 December 2020

Microsomal triglyceride transfer protein

1 reference

12 December 2020

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

1 reference

12 December 2020

Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome

1 reference

12 December 2020

Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome

1 reference

12 December 2020

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

12 December 2020

Identifiers

1 reference